ArticleJugan geon-gang gwa jilbyeong2025
HIV/AIDS Incidence, Treatment Status, and Mortality Statistics in the Republic of Korea, 2023.
Article in Jugan geon-gang gwa jilbyeong, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Commemoration of the Special Issue on HIV/AIDS in "Jugan geon-gang gwa jilbyeong · 2025Article
- HIV/AIDS Management Programs in Republic of Korea: Achievements and Future Direction.Jugan geon-gang gwa jilbyeong · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: In this study, we aim to assess the current status of human immunodeficiency virus (HIV) infection, HIV/acquired immune deficiency syndrome (AIDS) treatment, and AIDS-related mortality to support national strategies for HIV/AIDS prevention and management in the Republic of Korea. Methods: Statistics on HIV infection were analyzed using Integrated Disease Management System data, epidemiological surveys, health insurance and medical aid records, and national cause-of-death data. Results: In 2023, 1,005 new HIV infections were reported, including 749 Koreans (74.5%) and 256 foreigners (25.5%). Among these cases, 903 (89.9%) occurred in males. Individuals in their 30s constituted the largest proportion, accounting for 35.4% (356 people) of newly reported infections. Among those infected, 99.6% (564 people) reported sexual contact as the transmission route. In total, 16,963 people received HIV-related treatment in 2023. Among hospitalized patients, the mean length of stay was 32.6 days-longer than for pneumonia (22.6 days) and tuberculosis (22.1 days). There were 45 AIDS-related deaths in 2023. The number of people living with HIV in 2023 reached 16,459, an increase of 591 from the previous year. The proportion of cases among older adults aged ≥60 years has risen annually, increasing from 16.4% in 2020 to 19.4% in 2023. Conclusions: Strategic preparation is necessary to address the growing aging population living with HIV. Accordingly, the Korea Disease Control and Prevention Agency plans to implement strengthened policies under the 2nd National Action Plan on HIV/AIDS Prevention and Control (2024-2028) to reduce new infections, promote early detection, support timely treatment and adherence, protect the right to health, and enhance management capacity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.